Found: 1
Select item for more details and to access through your institution.
Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 437, doi. 10.1002/hon.3164_322
- By:
- Publication type:
- Article